Be SMART NIS, Moderate to Servere Asthma Patient Observation

This study has been completed.

First Received: August 9, 2007 Last Updated: March 26, 2009 History of Changes

Sponsored by:	AstraZeneca
Information provided by:	AstraZeneca
ClinicalTrials.gov Identifier:	NCT00514787

Purpose

Screen for moderate to severe asthma patients with suboptimal asthma control (as defined by GINA-Guidelines).

Document current asthma control status. Re-evaluate asthma therapy and document new therapy if applicable.

Condition
Asthma

Study Type:	Observational
Study Design:	Case-Only, Prospective
Official Title:	Be SMART NIS, Moderate to Servere Asthma Patient Observation

Resource links provided by NLM:

MedlinePlus related topics: Asthma

Further study details as provided by AstraZeneca:

Estimated Enrollment:

900

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00514787

Locations

Sponsors and Collaborators

AstraZeneca

Investigators

Study Chair:

Wolfgang Pohl, PHD

Executive Board OGP (Austria Society of Pneumology

More Information

No publications provided

Study ID Numbers:	NIS-RAT-SYM-2007/1
Study First Received:	August 9, 2007
Last Updated:	March 26, 2009
ClinicalTrials.gov Identifier:	NCT00514787 History of Changes
Health Authority:	Austria: Agency for Health and Food Safety

Keywords provided by AstraZeneca:

Asthma
NIS

Study placed in the following topic categories:

Hypersensitivity
Lung Diseases, Obstructive
Respiratory Tract Diseases
Bronchial Diseases

Lung Diseases
Hypersensitivity, Immediate
Asthma
Respiratory Hypersensitivity

Additional relevant MeSH terms:

Hypersensitivity
Lung Diseases, Obstructive
Immune System Diseases
Respiratory Tract Diseases
Bronchial Diseases

Lung Diseases
Hypersensitivity, Immediate
Asthma
Respiratory Hypersensitivity

ClinicalTrials.gov processed this record on September 04, 2009